Is Enanta Pharmaceuticals, Inc. overvalued?

Enanta Pharmaceuticals, Inc. (ENTA) — key valuation metrics and fundamentals.

No verdict

Price

$13.16

Fair value

—

Current P/E

—

Normal P/E

22.2

Market cap

$382.7M

Dividend yield

0.0%

Return on equity

-61.8%

Sector

Healthcare

Fair value compares ENTA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks